share_log

MAI Capital Management Raises Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

MAI Capital Management Raises Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

Mai資本管理公司增持安捷倫技術公司股票(紐約證券交易所代碼:A)
Defense World ·  2022/10/02 06:51

MAI Capital Management lifted its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Get Rating) by 5.1% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,800 shares of the medical research company's stock after acquiring an additional 183 shares during the quarter. MAI Capital Management's holdings in Agilent Technologies were worth $451,000 at the end of the most recent quarter.

根據Mai Capital Management向美國證券交易委員會(Securities And Exchange Commission)的最新披露,該公司在第二季度增持了安捷倫科技公司(Agilent Technologies,Inc.)的股票5.1%。該基金在本季度增持了183股後,持有這家醫學研究公司的3,800股股票。在最近一個季度末,Mai Capital Management持有的安捷倫科技股份價值451,000美元。

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Bridgewater Associates LP increased its position in Agilent Technologies by 18.6% in the fourth quarter. Bridgewater Associates LP now owns 6,466 shares of the medical research company's stock worth $1,032,000 after buying an additional 1,013 shares during the last quarter. Guggenheim Capital LLC boosted its holdings in shares of Agilent Technologies by 24.2% in the fourth quarter. Guggenheim Capital LLC now owns 36,056 shares of the medical research company's stock worth $5,756,000 after acquiring an additional 7,035 shares during the period. Caisse DE Depot ET Placement DU Quebec boosted its holdings in shares of Agilent Technologies by 23.1% in the fourth quarter. Caisse DE Depot ET Placement DU Quebec now owns 165,447 shares of the medical research company's stock worth $26,414,000 after acquiring an additional 31,000 shares during the period. Adage Capital Partners GP L.L.C. boosted its holdings in shares of Agilent Technologies by 22.1% in the fourth quarter. Adage Capital Partners GP L.L.C. now owns 322,594 shares of the medical research company's stock worth $51,502,000 after acquiring an additional 58,311 shares during the period. Finally, Camden Capital LLC bought a new position in shares of Agilent Technologies in the fourth quarter worth $231,000.

其他一些機構投資者和對衝基金最近也調整了對該公司的持股。Bridgewater Associates LP在第四季度將其在安捷倫技術公司的頭寸增加了18.6%。Bridgewater Associates LP現在擁有這家醫療研究公司6466股股票,價值103.2萬美元,在上個季度又購買了1013股。古根海姆資本有限責任公司在第四季度增持了24.2%的安捷倫技術公司的股票。古根海姆資本有限責任公司目前持有這家醫學研究公司36,056股股票,價值5756,000美元,在此期間又購買了7,035股。Caisse DE Depot et Placement DU魁北克在第四季度增持了23.1%的安捷倫科技股票。魁北克Caisse DE Depot et Placement DU現在擁有這家醫學研究公司165,447股股票,價值26,414,000美元,在此期間又購買了31,000股。Adage Capital Partners GP L.L.C.在第四季度將其持有的安捷倫科技股份增加了22.1%。Adage Capital Partners GP L.L.C.在此期間額外收購了58,311股,現在擁有這家醫學研究公司322,594股股票,價值51,502,000美元。最後,Camden Capital LLC在第四季度購買了價值231,000美元的安捷倫技術公司的新股票頭寸。

Get
到達
Agilent Technologies
安捷倫科技
alerts:
警報:

Wall Street Analysts Forecast Growth

華爾街分析師預測經濟增長

A number of equities analysts have recently commented on the company. Robert W. Baird raised their price target on Agilent Technologies from $155.00 to $160.00 and gave the stock an "outperform" rating in a report on Wednesday, August 17th. Credit Suisse Group assumed coverage on Agilent Technologies in a report on Wednesday, August 24th. They issued an "outperform" rating and a $165.00 price target for the company. Evercore ISI raised their price target on Agilent Technologies to $145.00 in a report on Monday, August 22nd. Bank of America raised their price target on Agilent Technologies from $148.00 to $155.00 and gave the stock a "buy" rating in a report on Wednesday, August 17th. Finally, UBS Group assumed coverage on Agilent Technologies in a research note on Wednesday, July 20th. They set a "buy" rating and a $139.00 price objective for the company. Four analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Agilent Technologies currently has an average rating of "Moderate Buy" and a consensus price target of $151.31.

一些股票分析師最近對該公司發表了評論。羅伯特·W·貝爾德將安捷倫科技公司的目標價從155.00美元上調至160.00美元,並在8月17日週三的一份報告中給出了該股“跑贏大盤”的評級。瑞士信貸集團在8月24日星期三的一份報告中對安捷倫科技進行了報道。他們給出了“跑贏大盤”的評級和165.00美元的目標價。在8月22日週一的一份報告中,Evercore ISI將安捷倫科技的目標價上調至145.00美元。美國銀行在8月17日週三的一份報告中將安捷倫科技的目標價從148.00美元上調至155.00美元,並給予該股“買入”評級。最後,瑞銀集團在7月20日星期三的一份研究報告中對安捷倫科技進行了報道。他們為該公司設定了“買入”評級和139.00美元的目標價。四位分析師對該股的評級為持有,九位分析師發佈了買入評級,一位分析師對該公司股票給予了強烈的買入評級。根據MarketBeat的數據,安捷倫科技目前的平均評級為“適度買入”,共識目標價為151.31美元。

Agilent Technologies Trading Down 1.0 %

安捷倫科技股價下跌1.0%

NYSE A opened at $121.55 on Friday. The stock's 50-day simple moving average is $130.78 and its two-hundred day simple moving average is $126.57. Agilent Technologies, Inc. has a twelve month low of $112.52 and a twelve month high of $165.68. The company has a quick ratio of 1.41, a current ratio of 1.94 and a debt-to-equity ratio of 0.54. The company has a market capitalization of $35.98 billion, a price-to-earnings ratio of 27.69, a PEG ratio of 2.42 and a beta of 1.06.
紐約證交所A股上週五開盤報121.55美元。該股的50日簡單移動均線切入位在130.78美元,200日簡單移動均線切入位在126.57美元。安捷倫科技公司股價跌至112.52美元的12個月低點和165.68美元的12個月高點。該公司的速動比率為1.41,流動比率為1.94,債務權益比率為0.54。該公司市值為359.8億美元,市盈率為27.69倍,聚乙二醇率為2.42倍,貝塔係數為1.06。

Agilent Technologies (NYSE:A – Get Rating) last released its quarterly earnings results on Tuesday, August 16th. The medical research company reported $1.34 earnings per share for the quarter, beating analysts' consensus estimates of $1.20 by $0.14. Agilent Technologies had a return on equity of 28.46% and a net margin of 19.94%. The business had revenue of $1.72 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter last year, the business posted $1.10 earnings per share. The company's revenue for the quarter was up 8.3% on a year-over-year basis. Research analysts forecast that Agilent Technologies, Inc. will post 5.07 EPS for the current fiscal year.

安捷倫科技公司(紐約證券交易所代碼:A-GET評級)最近一次發佈季度收益報告是在8月16日,星期二。這家醫學研究公司公佈,該季度每股收益為1.34美元,比分析師普遍預期的1.20美元高出0.14美元。安捷倫科技的股本回報率為28.46%,淨利潤率為19.94%。該業務本季度營收為17.2億美元,而市場普遍預期為16.4億美元。去年同一季度,該公司公佈的每股收益為1.10美元。該公司當季營收同比增長8.3%。研究分析師預測,安捷倫技術公司本財年每股收益將達到5.07歐元。

Agilent Technologies Dividend Announcement

安捷倫技術公司宣佈分紅

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 26th. Stockholders of record on Tuesday, October 4th will be issued a $0.21 dividend. The ex-dividend date is Monday, October 3rd. This represents a $0.84 annualized dividend and a dividend yield of 0.69%. Agilent Technologies's dividend payout ratio is currently 19.13%.

該公司最近還披露了季度股息,將於10月26日(星期三)支付。10月4日(星期二)登記在冊的股東將獲得0.21美元的股息。除股息日期為10月3日星期一。這意味着年化股息為0.84美元,股息收益率為0.69%。安捷倫科技目前的派息比率為19.13%。

Insider Transactions at Agilent Technologies

安捷倫技術公司的內幕交易

In other news, VP Padraig Mcdonnell sold 2,103 shares of Agilent Technologies stock in a transaction dated Wednesday, September 28th. The stock was sold at an average price of $122.89, for a total value of $258,437.67. Following the transaction, the vice president now owns 13,217 shares in the company, valued at $1,624,237.13. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

在其他新聞方面,副總裁帕德雷格·麥克唐奈在9月28日星期三的交易中出售了2,103股安捷倫技術公司的股票。這隻股票的平均售價為122.89美元,總價值為258,437.67美元。交易完成後,副總經理總裁現在擁有該公司13,217股,價值1,624,237.13美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可以通過這個環節.

About Agilent Technologies

關於安捷倫技術公司

(Get Rating)

(獲取評級)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

安捷倫技術公司為全球生命科學、診斷和應用化學品市場提供以應用為重點的解決方案。生命科學和應用市場部門提供液相色譜系統和部件;液相色譜質譜系統;氣相色譜系統和部件;氣相色譜-質譜儀系統;電感耦合等離子體質譜儀器;原子吸收儀器;微波等離子體原子發射光譜儀;電感耦合等離子光譜儀器;拉曼光譜;細胞分析平板分析;流式細胞儀;實時細胞分析儀;細胞成像系統;微孔板閲讀器;實驗室軟件;信息管理和分析;實驗室自動化和機器人系統;溶解測試;真空泵;以及測量技術。

Read More

閲讀更多內容

  • Get a free copy of the StockNews.com research report on Agilent Technologies (A)
  • EV Battery Maker Freyr Set For Major Global Expansion
  • MarketBeat: Week in Review 9/26 – 9/30
  • This Is A Memorable Time To Buy Into Micron Technology
  • How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
  • Let Paychex Stock Work Hard For You
  • 免費獲取StockNews.com關於安捷倫技術的研究報告(A)
  • 電動汽車電池製造商Freyr將在全球大舉擴張
  • MarketBeat:回顧一週9/26-9/30
  • 這是買入美光科技的難忘時刻
  • Keurig Dr Pepper與規模更大的競爭對手可口可樂(Coke&Pepsi)相比如何?
  • 讓Paychex股票為您努力工作

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Get Rating).

想看看其他對衝基金持有A的什麼嗎?訪問HoldingsChannel.com獲取安捷倫技術公司(紐約證券交易所代碼:A-GET評級)的最新13F文件和內幕交易。

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

接受安捷倫科技日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對安捷倫科技和相關公司的最新新聞和分析師評級的每日簡明摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論